In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumannii

Acinetobacter baumannii is currently classified as one of six pathogens that contribute to increased patient mortality. Thus, exploratory studies navigating alternative treatment strategies are of supreme interest. Herein, we completed minimum inhibitory concentration (MIC) testing, and time-kill an...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Antibiotics (Basel)
Hlavní autoři: Abdul-Mutakabbir, Jacinda C., Yim, Juwon, Nguyen, Logan, Maassen, Philip T., Stamper, Kyle, Shiekh, Zain, Kebriaei, Razieh, Shields, Ryan K., Castanheira, Mariana, Kaye, Keith S., Rybak, Michael J.
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8300792/
https://ncbi.nlm.nih.gov/pubmed/34356801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antibiotics10070880
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky